483 AstraZeneca Pharmaceuticals LP May 2003

483 AstraZeneca Pharmaceuticals LP May 2003

Jacqueline Diaz Albert FDA$595.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals LP - Frederick, MD, United States facility and issued inspectional observations (via FDA 483) on 16 May 2003.

Product details

  • Category: Biologics
  • Inspection end: 16 May 2003
  • Location: Frederick, United States
  • FEI: 3002617771
Add To Cart